Clinical Trial Update: Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 safety results for MK0928 in elderly patients with insomnia have been completed. The trial evaluated safety outcomes in this population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• MK0928

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Insomnia | Phase 3 | Status: COMPLETED